C. Dhelens

406 total citations
9 papers, 77 citations indexed

About

C. Dhelens is a scholar working on Epidemiology, Pharmacology and Pharmacology. According to data from OpenAlex, C. Dhelens has authored 9 papers receiving a total of 77 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Epidemiology, 2 papers in Pharmacology and 2 papers in Pharmacology. Recurrent topics in C. Dhelens's work include Attention Deficit Hyperactivity Disorder (2 papers), Pharmacy and Medical Practices (2 papers) and Cancer therapeutics and mechanisms (1 paper). C. Dhelens is often cited by papers focused on Attention Deficit Hyperactivity Disorder (2 papers), Pharmacy and Medical Practices (2 papers) and Cancer therapeutics and mechanisms (1 paper). C. Dhelens collaborates with scholars based in France and United States. C. Dhelens's co-authors include A. Gonçalves, J.P. Delord, Christine Toulas, Fabrice Pirot, Isabelle Lochon, Étienne Chatelut, C. Pivot, Nicolas Penel, Isabelle Hennebelle and Caroline Delmas and has published in prestigious journals such as Clinical Pharmacology & Therapeutics, Archives of Disease in Childhood and Journal of Neurology.

In The Last Decade

C. Dhelens

8 papers receiving 75 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C. Dhelens France	4	27	16	10	7	7	9	77
Steve Holliday United States	5	15 0.6×	27 1.7×	9 0.9×	2 0.3×	10 1.4×	8	96
Simone Spada Italy	8	10 0.4×	43 2.7×	2 0.2×	4 0.6×	4 0.6×	15	225
Patrick M. Brennan United States	3	19 0.7×	6 0.4×	3 0.3×	6 0.9×	10 1.4×	4	54
Ping-Wing Ng Singapore	3	47 1.7×	12 0.8×	19 1.9×	3 0.4×	3 0.4×	4	85
Östen Jonsson Sweden	5	42 1.6×	35 2.2×	3 0.3×	4 0.6×	11 1.6×	8	101
David Callacondo Peru	6	21 0.8×	28 1.8×	12 1.2×		6 0.9×	13	93
Barbara Wölfel Germany	3	10 0.4×	13 0.8×	5 0.5×	5 0.7×	2 0.3×	4	45
Viktoriya Korchina United States	3	8 0.3×	17 1.1×	3 0.3×	6 0.9×	2 0.3×	4	48
C. C. Guthrie United Kingdom	6	36 1.3×	26 1.6×	7 0.7×	8 1.1×	9 1.3×	12	175

Countries citing papers authored by C. Dhelens

Since Specialization

Citations

This map shows the geographic impact of C. Dhelens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Dhelens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Dhelens more than expected).

Fields of papers citing papers by C. Dhelens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Dhelens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Dhelens. The network helps show where C. Dhelens may publish in the future.

Co-authorship network of co-authors of C. Dhelens

This figure shows the co-authorship network connecting the top 25 collaborators of C. Dhelens. A scholar is included among the top collaborators of C. Dhelens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Dhelens. C. Dhelens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Portefaix, Aurélie, C. Dhelens, Morgan Recher, et al.. (2024). High-dose intravenous immunoglobulin versus albumin 4% in paediatric toxic shock syndrome: a randomised controlled feasibility study. Archives of Disease in Childhood. 109(9). 717–723. 2 indexed citations

Laurencin, Chloé, Ana Marquès, Caroline Giordana, et al.. (2023). Efficacy and safety of clonidine for the treatment of impulse control disorder in Parkinson’s disease: a multicenter, parallel, randomised, double-blind, Phase 2b Clinical trial. Journal of Neurology. 270(10). 4851–4859. 11 indexed citations

Bertholet‐Thomas, Aurélia, Aurélie Portefaix, C. Dhelens, et al.. (2022). Fluconazole in hypercalciuric patients with increased 1,25(OH)2D levels: the prospective, randomized, placebo-controlled, double-blind FLUCOLITH trial. Trials. 23(1). 499–499. 2 indexed citations

Dhelens, C., et al.. (2019). Perfusion continue d’oxacilline en diffuseur élastomérique : quelle stabilité physico-chimique en pratique clinique ?. Médecine et Maladies Infectieuses. 49(4). S8–S8. 1 indexed citations

Barbier, F., et al.. (2019). Quelles sont nos pratiques cliniques avec la Daptomycine ?. Médecine et Maladies Infectieuses. 49(4). S60–S60.

Dhelens, C., et al.. (2017). Formulation, stability testing, and analytical characterization of melatonin-based preparation for clinical trial. Journal of Pharmaceutical Analysis. 7(4). 237–243. 21 indexed citations

Thomas, Fabienne, Isabelle Hennebelle, Caroline Delmas, et al.. (2015). Genotyping of a family with a novel deleterious DPYD mutation supports the pretherapeutic screening of DPD deficiency with dihydrouracil/uracil ratio. Clinical Pharmacology & Therapeutics. 99(2). 235–242. 31 indexed citations

Drai, Jocelyne, Vincent Lépilliez, Mathieu Pioche, et al.. (2014). Validation du procédé aseptique et étude de stabilité d’une préparation injectable de fructose (5 %)–glycérol (10 %) dans le cadre d’un programme hospitalier de recherche clinique portant sur le traitement curatif endoscopique des lésions néoplasiques épithéliales précoces du tube digestif. Annales Pharmaceutiques Françaises. 73(2). 139–149. 6 indexed citations

Dhelens, C., et al.. (2014). Implication pharmaceutique dans le cadre d’essais cliniques institutionnels : évaluation de la qualité des opérations de mise sous forme pharmaceutique. Annales Pharmaceutiques Françaises. 73(3). 197–214. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact